Interestingly, a high prevalence of deletions in CFH-related genes 3 and 1 (CFHR3-CFHR1) have been detected in pediatric cancer patients post-hematopoietic stem cell transplant (HSCT) [49]. Here, CFHR1 is linked to cancer.